These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12695018)
21. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model. Safwat MA; Soliman GM; Sayed D; Attia MA Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979 [TBL] [Abstract][Full Text] [Related]
22. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Mayer LD; Tai LC; Bally MB; Mitilenes GN; Ginsberg RS; Cullis PR Biochim Biophys Acta; 1990 Jun; 1025(2):143-51. PubMed ID: 2364073 [TBL] [Abstract][Full Text] [Related]
23. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity. Yan C; Chen D; Gu J; Qin J J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175 [TBL] [Abstract][Full Text] [Related]
24. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Mura P; Maestrelli F; González-Rodríguez ML; Michelacci I; Ghelardini C; Rabasco AM Eur J Pharm Biopharm; 2007 Aug; 67(1):86-95. PubMed ID: 17350813 [TBL] [Abstract][Full Text] [Related]
25. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Tardi PG; Gallagher RC; Johnstone S; Harasym N; Webb M; Bally MB; Mayer LD Biochim Biophys Acta; 2007 Mar; 1768(3):678-87. PubMed ID: 17208196 [TBL] [Abstract][Full Text] [Related]
26. Effect of beta-sitosterol concentration and high pressure homogenization on the chlorhexidine release from vesicular gels. Farkas E; Schubert R; Zelkó R Int J Pharm; 2006 Jan; 307(1):51-5. PubMed ID: 16257155 [TBL] [Abstract][Full Text] [Related]
27. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization. Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856 [TBL] [Abstract][Full Text] [Related]
28. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Bozkir A; Saka OM Farmaco; 2005 Oct; 60(10):840-6. PubMed ID: 16087183 [TBL] [Abstract][Full Text] [Related]
29. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720 [TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation. Changsan N; Chan HK; Separovic F; Srichana T J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099 [TBL] [Abstract][Full Text] [Related]
31. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network. Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095 [TBL] [Abstract][Full Text] [Related]
32. Characterization of pH- and temperature-sensitive hydrogel nanoparticles for controlled drug release. Chen H; Gu Y; Hub Y; Qian Z PDA J Pharm Sci Technol; 2007; 61(4):303-13. PubMed ID: 17933211 [TBL] [Abstract][Full Text] [Related]
33. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Padamwar MN; Pokharkar VB Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237 [TBL] [Abstract][Full Text] [Related]
34. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition. Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911 [TBL] [Abstract][Full Text] [Related]
35. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity. Gaur PK; Bajpai M; Mishra S; Verma A Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229 [TBL] [Abstract][Full Text] [Related]
36. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. Bhatia A; Kumar R; Katare OP J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383 [TBL] [Abstract][Full Text] [Related]
37. Steam sterilisation of vesicular phospholipid gels. Tardi C; Drechsler M; Bauer KH; Brandl M Int J Pharm; 2001 Apr; 217(1-2):161-72. PubMed ID: 11292552 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique. Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846 [TBL] [Abstract][Full Text] [Related]
39. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system. Kumar RV; Sinha VR Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913 [TBL] [Abstract][Full Text] [Related]
40. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]